Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial

Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clin

(2011) Carsten Rygaard Hjorthøj et al.   ADDICTION

Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances — Systematic review and meta-analysis

(2011) Carsten Rygaard Hjorthøj et al.   ADDICTIVE BEHAVIORS

Pharmacological Treatment of Cannabis Dependence

(2011) A. M. Weinstein et al.   CURRENT PHARMACEUTICAL DESIGN

Motivational Intervention to Reduce Cannabis Use in Young People with Psychosis: A Randomized Controlled Trial

(2011) Charles Bonsack et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia

(2011) V. C. Leeson et al.   SCHIZOPHRENIA BULLETIN

CONSORT 2010 changes and testing blindness in RCTs

(2010) Kenneth F Schulz et al.   LANCET

The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample

(2010) M. Yucel et al.   SCHIZOPHRENIA BULLETIN

Treatment of cannabis use disorders in people with schizophrenia spectrum disorders — A systematic review

(2009) Carsten Hjorthøj et al.   ADDICTIVE BEHAVIORS

Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis

(2008) Carsten Hjorthøj et al.   Trials